DCTH
Price
$15.34
Change
-$0.30 (-1.92%)
Updated
Jun 13 closing price
Capitalization
109.8M
58 days until earnings call
QDEL
Price
$28.90
Change
-$0.98 (-3.28%)
Updated
Jun 13 closing price
Capitalization
3.14B
47 days until earnings call
Interact to see
Advertisement

DCTH vs QDEL

Header iconDCTH vs QDEL Comparison
Open Charts DCTH vs QDELBanner chart's image
Delcath Systems
Price$15.34
Change-$0.30 (-1.92%)
Volume$316.42K
Capitalization109.8M
QuidelOrtho
Price$28.90
Change-$0.98 (-3.28%)
Volume$927.96K
Capitalization3.14B
DCTH vs QDEL Comparison Chart
Loading...
DCTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DCTH vs. QDEL commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DCTH is a Hold and QDEL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (DCTH: $15.34 vs. QDEL: $28.90)
Brand notoriety: DCTH and QDEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DCTH: 65% vs. QDEL: 58%
Market capitalization -- DCTH: $109.8M vs. QDEL: $3.14B
DCTH [@Medical Specialties] is valued at $109.8M. QDEL’s [@Medical Specialties] market capitalization is $3.14B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DCTH’s FA Score shows that 1 FA rating(s) are green whileQDEL’s FA Score has 1 green FA rating(s).

  • DCTH’s FA Score: 1 green, 4 red.
  • QDEL’s FA Score: 1 green, 4 red.
According to our system of comparison, DCTH is a better buy in the long-term than QDEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DCTH’s TA Score shows that 6 TA indicator(s) are bullish while QDEL’s TA Score has 5 bullish TA indicator(s).

  • DCTH’s TA Score: 6 bullish, 4 bearish.
  • QDEL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DCTH is a better buy in the short-term than QDEL.

Price Growth

DCTH (@Medical Specialties) experienced а -6.35% price change this week, while QDEL (@Medical Specialties) price change was -2.13% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.91%. For the same industry, the average monthly price growth was +1.14%, and the average quarterly price growth was +0.34%.

Reported Earning Dates

DCTH is expected to report earnings on Aug 11, 2025.

QDEL is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (-1.91% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QDEL($3.14B) has a higher market cap than DCTH($110M). DCTH has higher P/E ratio than QDEL: DCTH (212.77) vs QDEL (9.76). DCTH YTD gains are higher at: 27.409 vs. QDEL (-35.129). QDEL has higher annual earnings (EBITDA): 607M vs. DCTH (-46.11M). QDEL has more cash in the bank: 167M vs. DCTH (32.5M). DCTH has less debt than QDEL: DCTH (10.2M) vs QDEL (2.61B). QDEL has higher revenues than DCTH: QDEL (3B) vs DCTH (2.07M).
DCTHQDELDCTH / QDEL
Capitalization110M3.14B4%
EBITDA-46.11M607M-8%
Gain YTD27.409-35.129-78%
P/E Ratio212.779.762,181%
Revenue2.07M3B0%
Total Cash32.5M167M19%
Total Debt10.2M2.61B0%
FUNDAMENTALS RATINGS
DCTH vs QDEL: Fundamental Ratings
DCTH
QDEL
OUTLOOK RATING
1..100
646
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
9693
PRICE GROWTH RATING
1..100
3887
P/E GROWTH RATING
1..100
114
SEASONALITY SCORE
1..100
4075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QDEL's Valuation (55) in the Medical Specialties industry is somewhat better than the same rating for DCTH (90). This means that QDEL’s stock grew somewhat faster than DCTH’s over the last 12 months.

DCTH's Profit vs Risk Rating (69) in the Medical Specialties industry is in the same range as QDEL (100). This means that DCTH’s stock grew similarly to QDEL’s over the last 12 months.

QDEL's SMR Rating (93) in the Medical Specialties industry is in the same range as DCTH (96). This means that QDEL’s stock grew similarly to DCTH’s over the last 12 months.

DCTH's Price Growth Rating (38) in the Medical Specialties industry is somewhat better than the same rating for QDEL (87). This means that DCTH’s stock grew somewhat faster than QDEL’s over the last 12 months.

DCTH's P/E Growth Rating (1) in the Medical Specialties industry is in the same range as QDEL (14). This means that DCTH’s stock grew similarly to QDEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DCTHQDEL
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 27 days ago
82%
Bullish Trend 4 days ago
68%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
DCTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSMBX36.15N/A
N/A
Horizon Multi-Factor Small/Mid Cap Adv
MSBWX11.93N/A
N/A
Morgan Stanley American Resilience C
NCIGX30.98-0.41
-1.31%
Nuveen International Value C
HFMSX31.92-0.52
-1.60%
Hartford MidCap R4
NEFJX18.39-0.31
-1.66%
Natixis Vaughan Nelson Small Cap A

DCTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DCTH has been loosely correlated with CLPT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if DCTH jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DCTH
1D Price
Change %
DCTH100%
-1.92%
CLPT - DCTH
37%
Loosely correlated
-4.47%
QDEL - DCTH
37%
Loosely correlated
-3.28%
NVST - DCTH
35%
Loosely correlated
-2.23%
MMSI - DCTH
35%
Loosely correlated
-0.65%
ISRG - DCTH
35%
Loosely correlated
-0.16%
More

QDEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, QDEL has been loosely correlated with BIO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if QDEL jumps, then BIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QDEL
1D Price
Change %
QDEL100%
-3.28%
BIO - QDEL
51%
Loosely correlated
-2.37%
DHR - QDEL
51%
Loosely correlated
-2.16%
ITGDF - QDEL
50%
Loosely correlated
N/A
RVTY - QDEL
50%
Loosely correlated
-2.27%
XRAY - QDEL
50%
Loosely correlated
-2.37%
More